Cognizant, NVIDIA

Cognizant aplicará IA generativa para aprimorar a descoberta de medicamentos para clientes farmacêuticos com NVIDIA BioNeMo

Published on 08/07/2025 at 18:02 | prnewswire.co.uk

Cognizant Benin Burkina Faso Burundi Cameroon Chad Comoros Cote d'Ivoire Djibouti Ethiopia Gabon Gambia Ghana Guinea Equatorial Guinea Kenya Liberia Madagascar Mali Namibia Niger Nigeria Central African Republic Congo, The Democratic Republic of the Congo, The Republic of the Senegal Sierra Leone South Africa Sudan Tanzania Tonga Uganda Zambia Zimbabwe Algeria Angola Botswana Cape Verde Egypt Eritrea Guinea-Bissau Lesotho Libya Malawi Mauritania Mauritius Morocco Mozambique Rwanda Sao Tome and Principe Seychelles South Sudan Swaziland Togo Tunisia New Jersey

View original content:https://www.prnewswire.com/br/comunicados-para-a-imprensa/cognizant-aplicara-ia-generativa-para-aprimorar-a-descoberta-de-medicamentos-para-clientes-farmaceuticos-com-nvidia-bionemo-302093797.html

FONTE Cognizant

en | US67066G1040 | COGNIZANT | boerse | 68003228 |